SMS Pharmaceuticals Ltd Share Price
(SMSPHARMA)
₹242.08▲0.72%
as on 11:17AM, 28 Apr 2025
Sms Pharma Performance
Day's Low
Day's High
₹236.2Day's Price Range₹245.852 Week's Low
52 Week's High
₹175.2552-Week Price Range₹398
| Returns % | |
| 1 Month Return | + 12.96 % |
| 3 Month Return | + 26.89 % |
| 1 Year Return | + 15.75 % |
| Market Stats | |
| Previous Close | ₹240.35 |
| Open | ₹242.04 |
| Volume | 83.15K |
| Upper Circuit | ₹288.42 |
| Lower Circuit | ₹192.28 |
| Market Cap | ₹2,130.75Cr |
Sms Pharma Fundamentals
P/E Ratio
30.77
PEG Ratio
9.53
Market Cap
₹2,130.75 Cr
P/B Ratio
2.78
EPS
5.81
Dividend Yield
0.22
Sector
Pharmaceuticals
ROE
9.28
Mutual Fund Holdings of Sms Pharma
| Funds | Holdings | Prev. 5M |
|---|---|---|
 Quant Small Cap Fund Growth Option Direct Plan | 0.13% | |
| Quant Healthcare Fund Direct Growth | 3.81% | |
 Bandhan BSE Healthcare Index Fund Direct Growth | 0.05% |
Key events for SMS Pharmaceuticals Ltd
SMS Pharma Completes USFDA Inspection Successfully - 22 Mar, 2025
SMS Pharmaceuticals' Hyderabad facility successfully completed a USFDA inspection with one procedural observation. The company reported a 58.9% increase in Q3 FY25 net profit, reflecting strong operational performance.SMS Pharma Reports Strong Q4 Results for December 2024 - 28 Feb, 2025
SMS Pharmaceuticals reported a 7.35% increase in net sales to Rs 173.35 crore for December 2024, with net profit rising 58.9% to Rs 18.24 crore. EBITDA also grew by 15.91%. However, shares have declined 41.68% over the last six months.
Insights on SMS Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, SMSPHARMA stock has moved up by 10.8%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 14.1 Cr → 18.24 Cr (in ₹), with an average increase of 22.7% per quarter
- POSITIVE IMPACT
Promoter Holding Up
Promoters have increased holdings from 64.67% to 66.26% in Mar 2025 quarter
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 139.1% return, outperforming this stock by 3.2%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 50.7% return, outperforming this stock by 35.0%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 198.05 Cr → 175.48 Cr (in ₹), with an average decrease of 11.4% per quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 0.31% to 0.08% in Mar 2025 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 2.55% to 2.43% in Mar 2025 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 32.47% to 31.22% in Mar 2025 quarter
Sms Pharma Financials
Sms Pharma Index Inclusions
Sms Pharma Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 66.26% | 0.00 | |
| Foreign Institutions | 0.08% | 0.00 | |
| Mutual Funds | 2.43% | 0.00 | |
| Retail Investors | 31.22% | 0.00 | |
| Others | 0% | 0.00 |
Sms Pharma Key Indicators
Sms Pharma Valuation
Sms Pharma in the last 5 years
Lowest (-163.97x)
June 20, 2023
Today (30.77x)
April 25, 2025
Industry (55.10x)
April 25, 2025
Highest (2093.00x)
November 11, 2022
Sms Pharma Earnings and Dividends
SMS Pharmaceuticals Ltd Earnings Results
SMS Pharmaceuticals Ltd’s net profit jumped 58.89% since last year same period to ₹18.24Cr in the Q3 2024-2025. On a quarterly growth basis, SMS Pharmaceuticals Ltd has generated 29.36% jump in its net profits since last 3-months.
Read More about Earnings ResultsSMS Pharmaceuticals Ltd Dividends May,2024
In the quarter ending March 2024, SMS Pharmaceuticals Ltd has declared dividend of ₹0.40 - translating a dividend yield of 0.17%.
Read More about Dividends
Sms Pharma Technicals Summary
Bearish
Neutral
Bullish
SMS Pharmaceuticals Ltd is currently in a Bullish trading position according to technical analysis indicators.
Sms Pharma Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹2,130.75 Cr | 97.96% | 0.67 | ₹49 Cr | ₹709 Cr | |
| NA | ₹152.47 Cr | 7.14% | 0.51 | NA | NA | |
| NA | ₹227.58 Cr | 79.23% | 0.52 | ₹16 Cr | ₹108 Cr | |
| NA | ₹3,189.94 Cr | 36.3% | 0.65 | -₹2 Cr | ₹559 Cr | |
| NA | ₹3,223.06 Cr | 49.4% | 0.53 | ₹96 Cr | ₹1,690 Cr |
About Sms Pharma
Revenue: ₹173.35Cr as on December 2024 (Q4 24)
Net Profit: ₹17.08Cr as on December 2024 (Q4 24)
Listing date: 28 Feb, 2007
Chairperson Name: P Ramesh Babu
| Organisation | Sms Pharma |
| Headquarters | Hyderabad |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on SMS Pharmaceuticals Ltd
What is SMS Pharmaceuticals Ltd price today?
SMS Pharmaceuticals Ltd share price today stands at ₹242.08, Open: ₹242.04, Previous Close: ₹240.35, High: ₹245.8, Low: ₹236.2, 52 Week High: ₹398, 52 Week Low: ₹175.25.
How to Buy SMS Pharmaceuticals Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy SMS Pharmaceuticals Ltd shares
What are today's traded volumes of SMS Pharmaceuticals Ltd?
Today's traded volume of SMS Pharmaceuticals Ltd(SMSPHARMA) is 83.15K.
What is today's market capitalisation of SMS Pharmaceuticals Ltd?
Today's market capitalisation of SMS Pharmaceuticals Ltd(SMSPHARMA) is ₹2130.75Cr.
What is the 52 Week High and Low Range of SMS Pharmaceuticals Ltd?
How much percentage SMS Pharmaceuticals Ltd is down from its 52 Week High?
SMS Pharmaceuticals Ltd (SMSPHARMA) share price is ₹242.08. It is down -39.18% from its 52 Week High price of ₹398
How much percentage SMS Pharmaceuticals Ltd is up from its 52 Week low?
SMS Pharmaceuticals Ltd (SMSPHARMA) share price is ₹242.08. It is up 38.13% from its 52 Week Low price of ₹175.25